Positions

Overview

  • Introduction:

    Dr. Paschal received her medical degree from the University of South Florida in Tampa. She completed her Internal Medicine Residency and her Hematology/Oncology Fellowship training at Vanderbilt University Medical Center in Nashville.

    Clinical Interests & Research:

    Dr. Paschal focuses on benign hematology including coagulation and sickle cell disease.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Congenital and acquired disorders of secondary hemostasis 2022
    2022 Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform.  Jco Oncology Practice.  18:E36-E46. 2022
    2021 Questioning the association between ABO type and outcomes in patients with COVID-19.  Annals of Hematology.  100:3081-3082. 2021
    2021 Cancer-associated venous thromboembolic disease, version 2.2021.  Journal of the National Comprehensive Cancer Network : JNCCN.  19:1181-1201. 2021
    2018 NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines.  Journal of the National Comprehensive Cancer Network : JNCCN.  16:1289-1303. 2018
    2016 Perioperative management in sickle cell disease.  Southern Medical Journal.  109:557-559. 2016
    2016 Rasburicase-induced methemoglobinemia: Case report, literature review, and proposed treatment algorithm.  Clinical Case Reports.  4:315-319. 2016
    2015 Cancer-associated venous thromboembolic disease, version 1.2015: Featured updates to the NCCN Guidelines.  Journal of the National Comprehensive Cancer Network : JNCCN.  13:1079-1095. 2015
    2015 Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.  Journal of the National Comprehensive Cancer Network : JNCCN.  13:424-434. 2015
    2013 Resolution of Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) after multidrug therapy with rituximab: A case report and review of the literature.  Haemophilia.  19. 2013
    2013 Development of factor VIII inhibitors in two patients with moderate haemophilia A.  Haemophilia.  19. 2013

    Research Overview

  • Medical education
    Hemostasis and thrombosis

    • Principal Investigator On

    Investigator On

    Education And Training

  • Vanderbilt University Medical Center, Internship
  • Vanderbilt University Medical Center, Residency
  • Vanderbilt University Medical Center, Postdoctoral Fellowship
  • Doctor of Medicine, University of South Florida 2006
  • Bachelor of Science or Mathematics in Biology, Georgia Southern University 2001

    • Full Name

  • Rita Paschal